![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Bajaj Healthcare Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Carbamazepine, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 2002-141 - Rev 00
This Chemical Type CEP, issued on March 11, 2011, remains in force until July 01, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 543 associated with this CEP further emphasizes